Key Takeaways A three-year study of tirzepatide—the active ingredient in Eli Lilly’s injectable weight-loss drug …
Tag:
Lilly
-
-
BusinessHealth CareNews
Eli Lilly weight loss drug cuts risk of developing diabetes in trial
by adminAn Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New …
-
An Eli Lilly & Co. Zepbound injection pen, March 28, 2024. Bloomberg | Bloomberg | …
-
Mutual FundsNews
Eli Lilly Stock Finishes Lower After News of Bond Sale to Fund Morphic Deal
by adminKey Takeaways Eli Lilly is selling bonds to fund the acquisition of drug developer Morphic. …
-
Key Takeaways It was a second straight day of gains for Eli Lilly shares following …
-
-
<img src='https://www.investopedia.com/thmb/aiN_Ewwd6ImKqmfeJ97Z88CpPv4=/filters:no_upscale():max_bytes(150000):strip_icc():format(jpeg)/GettyImages-20924813401-381b104f98ce457b8dd530d94c41390b.jpg' alt=' Scott Olson / Staff / Getty Images ‘ title=”Eli Lilly headquarters”> Scott …
-
Mutual FundsNews
Eli Lilly Stock Soars as Mounjaro, Zepbound Power Earnings Beat, Guidance Boost
by adminKey Takeaways Eli Lilly shares soared Thursday after the Mounjaro and Zepbound maker posted better …
-
The Eli Lilly logo is shown on one of the company’s offices in San Diego, …
-
-
-
BusinessHealth CareNews
Eli Lilly weight loss drug Zepbound cuts heart failure risks in study
by adminAn Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New …
-
<img src='https://www.investopedia.com/thmb/sPfhNywBYSS3woRZDjognw3jn5k=/filters:no_upscale():max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1302141479-6ca75964e9904549b66d2eee33b8125e.jpg' alt=' Cristina Arias / Contributor / Getty Images ‘ title=”Eli Lilly”> Cristina Arias …
-